Home Blog Page 1178

U.S. Investing Champion J Law Expands to Singapore After Record Two-Year Run

SINGAPORE, Feb. 27, 2026 /PRNewswire/ — Law Wai-Sum, a Hong Kong trader known as J Law, is expanding his investment education business, JLawStock, to Singapore after posting a record 1,499% cumulative return over two years in the top division of the United States Investing Championship.

The move marks the first phase of Law’s broader international expansion, with Singapore serving as the base to engage retail investors seeking more systematic and professional approaches to trading.

A Historic Achievement in a Four-Decade Competition

Founded in 1983 by Norman Zada, then a visiting scholar at Stanford University, the United States Investing Championship tracks verified real-money accounts and publishes audited performance rankings across multiple divisions. Over the past four decades, participants have included hedge fund managers such as Paul Tudor Jones and Louis Bacon, as well as trading legends including David Ryan and Mark Minervini.

According to official results, Law won the $1 million-plus stock division with a 353.9% return in 2024, followed by a 252.3% gain in 2025, becoming the first Asia-based trader to secure consecutive titles in the top-tier category.

His combined two-year return of 1,499% set a new record for the division. Over the same period, the S&P 500 gained about 47%, as noted by the competition organizers.

Law Picks Singapore as Hub for Education Expansion

Following a record two-year performance in trading competition, Law is expanding his investment education business and positioning Singapore as the regional hub for JLawStock.

JLawStock offers structured trading frameworks for retail investors. Its curriculum emphasizes professional trading techniques, discipline and the mindset required for long-term market participation. The programs have attracted full-time traders, financial influencers, and fund managers.  

As part of its global growth strategy, the firm is establishing Singapore as its regional base and has launched an English-language YouTube channel aimed at a broader international audience.

Law described Singapore as a leading asset- and wealth-management center with a regulatory framework that supports structured investment practices.

“Singapore is a global capital hub where investors value discipline and process,” he said. “The regulatory environment and the sophistication of the financial ecosystem are aligned with JLawStock’s long-term mission.”

He said the objective is to translate trading methodologies developed in U.S. markets into practical educational frameworks for retail investors in the region.

Expanding Access to a Champion-Level Framework

Against a backdrop of elevated global market volatility, Law said financial literacy and risk management are becoming increasingly important for retail investors participating in international equities.

In Singapore, he plans to introduce his trading framework, the Multiple-Edge Trading Strategy, or M.E.T.S., a rules-based system that integrates price-structure analysis, capital allocation, trading discipline and market psychology, with risk control at its core. The goal, he said, is to make the approach accessible to a broader base of investors and traders seeking to improve consistency.

“Most people focus on finding a magic strategy,” he said. “What makes performance repeatable is a process that reduces costly mistakes and puts risk control first.”

Law, who trades U.S. markets from Asia, also said time differences are not the primary challenge.

“Time zones aren’t the real issue — emotional trading is,” he said. “Success depends on preparation and identifying favorable risk-reward setups before the opening bell.”

Looking ahead, Law said he is exploring potential partnerships with Singapore-based fintech firms and licensed brokerages as part of the expansion, aimed at broadening access to structured trading education for retail participants in global markets.

About the United States Investing Championship

Founded in 1983, the United States Investing Championship is a real-money investing competition that tracks participants’ performance across multiple divisions and publishes annual standings.

About J Law (Law Wai-Sum)

J Law is a two-time world champion of the United States Investing Championship ($1,000,000+ Stock Division). He holds the competition’s all-time two-year cumulative return record of +1,499%, achieved through verified real-money trading. As a pragmatic investment educator, J Law specializes in systematic market analysis and risk management. He runs widely popular investment channels, aiming to share world-class trading psychology and frameworks with a global audience.

Disclaimer: This release is for informational and educational purposes only and does not constitute personalized investment advice. Past performance does not guarantee future results.

Sources:

https://financial-competitions.com/
https://x.com/USICOfficial/status/2010490410171502877

vivo Announces MWC 2026 Attendance; Set to Showcase New Flagship X300 Ultra

BARCELONA, Spain, Feb. 27, 2026 /PRNewswire/ — vivo today announced its attendance at Mobile World Congress 2026 (MWC 2026), taking place in Barcelona from March 2 to 5. At the event, vivo will offer the first global preview of its upcoming flagship, the X300 Ultra, and present its key conference message for the future of mobile innovation under the theme “Where Vision Meets.”

vivo’s debut at MWC marks a strategic milestone in its evolution as a global technology leader, reflecting the company’s commitment to deepening its global presence and advancing its premium portfolio. As one of the world’s most influential platforms for mobile technology, MWC offers vivo a global stage to engage with international media, industry leaders, operators, and partners, while demonstrating its long-term commitment to high-end innovation.

At the center of vivo’s MWC 2026 showcase will be the preview of the X300 Ultra, providing an early look at vivo’s latest premium design language and imaging advancements.

The X300 Ultra represents vivo’s most advanced exploration to date in mobile imaging and videography, building on the company’s continued investment in optics engineering, computational photography, and system-level optimization.

Visitors to the vivo booth will experience the uniquely inspired design of the X300 Ultra, drawn from the company’s professional imaging heritage. In addition, vivo will showcase a broader lineup of products at MWC 2026, including the X300 Series, vivo X Fold5, V70 Series, with hands-on demonstrations to illustrate how advanced technologies in imaging, AI, and system performance translate into intuitive, human-centered experiences.

vivo’s presence at MWC 2026 underscores its steadfast commitment to engaging more deeply with the global mobile ecosystem and competing at the forefront of the premium segment. By bringing together product innovation, refined design, and ecosystem collaboration, vivo aims to demonstrate how technology can enhance perception, expression, and connection in everyday life.

About vivo

vivo is a technology company that creates great products based on a design-driven value, with smart devices and intelligent services as its core. The company aims to build a bridge between humans and the digital world. Through unique creativity, vivo provides users with an increasingly convenient mobile and digital life. Following the company’s core values, which include Benfen*, user-orientation, design-driven value, continuous learning and team spirit, vivo has implemented a sustainable development strategy with the vision of developing into a healthier, more sustainable world-class corporation.

While bringing together and developing the best local talents to deliver excellence, vivo is supported by a network of R&D centers in Shenzhen, Dongguan, Nanjing, Beijing, Hangzhou, Shanghai, Xi’an and more cities, focusing on the development of state-of-the-art consumer technologies, including 5G, artificial intelligence, industrial design, imaging system and other up-and-coming technologies. vivo has also set up an intelligent manufacturing network (including those authorized by vivo), with an annual production capacity of nearly 200 million smartphones. As of now, vivo has branched out its sales network across more than 60 countries and regions, and is loved by more than 500 million users worldwide.

*”Benfen” is a term describing the attitude on doing the right things and doing things right – which is the ideal description of vivo’s mission to create value for society.

Stay informed of latest vivo news at https://www.vivo.com/en/about-vivo/news 

 

Fosun International Receives “Certificate of Excellence in Environmental, Social and Governance Reporting” from Hong Kong Management Association

HONG KONG, Feb. 27, 2026 /PRNewswire/ — On 23 February 2026, The Hong Kong Management Association (HKMA) held the 2025 HKMA Best Annual Reports Awards presentation ceremony in Hong Kong. Fosun International received the “Certificate of Excellence in Environmental, Social and Governance Reporting”, underscoring the company’s outstanding performance in ESG strategy, environmental protection, social responsibility, corporate governance and information disclosure, and its continued recognition by industry authorities.

Since its inception in 1973, the HKMA Best Annual Reports Awards has become a highly regarded benchmark in Hong Kong’s information disclosure landscape. It aims to award and recognize organizations for their achievement in annual report preparation.

A total of nine enterprises received the “Certificate of Excellence in Environmental, Social and Governance Reporting”. Other award-winning companies include CLP Holdings, CK Hutchison Holdings, Hong Kong Exchanges and Clearing Limited, MTR Corporation, Swire Properties, Chow Tai Fook Jewellery, S.F. Holding, Lenovo Group, and The Hongkong and Shanghai Hotels, all of which are prominent blue-chip listed companies.

HKMA pointed out that the award-winning companies have significantly enhanced ESG governance by incorporating ESG into their long-term development strategies and key future initiatives. They also align with international climate-related information disclosure standards such as the Task Force on Climate-related Financial Disclosures (TCFD), while demonstrating management’s active engagement and strong commitment to ecosystems and biodiversity.

In 2023, Fosun established the “Create IMPACT” sustainable development strategy, built on six key pillars: Innovation-driven, Mindful Operation, People and Partner Oriented, Advanced Governance, Climate and Planet Positive and Transparency, to systematically integrate ESG principles into its business strategy.

I: Innovation-driven

M: Mindful Operation

P: People and Partner Oriented

A: Advanced Governance

C: Climate and Planet Positive

T: Transparency

Since its establishment in 1992, Fosun has developed into a global innovation-driven consumer group with businesses in more than 40 countries and regions. With the original aspiration of “Self-improvement, Teamwork, Performance, and Contribution to Society”, Fosun remains committed to developing business for good. While advancing robust business development, Fosun continuously optimizes its sustainable development strategy to address profound shifts in the global economy, society, and environment, ensuring long-term competitiveness alongside social value creation.

Actively responding to climate change and promoting low-carbon transformation

In response to climate change challenges, the Group has transitioned from passive adaptation to proactive participation and innovation. At top-level governance, under the coordination of the Board of Directors (the “Board”) and the Carbon Neutrality Committee, Fosun has achieved several key milestones, such as incorporating carbon neutrality indicators into the performance appraisal of the management, establishing a carbon emission management system and audit standards, and conducting greenhouse gas inventory training across the Group. In terms of technology-driven low-carbon transformation, the Group has accelerated the adoption of low-carbon technologies, leveraging innovative approaches to drive green transformation across its industrial chain and continuously provide sustainable products and services to consumers. In terms of financial innovation, In September 2025, Fosun held the signing ceremony in Hong Kong for its three-year sustainability-linked syndicated loan. The total syndicated amount was further increased to USD990 million equivalent, setting a new record for the largest offshore syndicated loan by a Chinese private enterprise in 2025. This achievement has effectively supported the implementation of the Group’s sustainable development strategy.

Fosun actively responds to the national “dual carbon” goals by promoting carbon neutrality, energy conservation and emission reduction. In 2021, Fosun made a commitment to society – “strive to peak carbon emissions by 2028 and achieve carbon neutrality by 2050”. Fosun has formulated strategies for climate change mitigation and adaptation in support of the Paris Agreement’s global temperature control framework. As Hong Kong Stock Exchange’s New Climate Requirements came into effect in 2025, Fosun International further aligned with the International Financial Reporting Standards S2 Climate-related Disclosures Requirements (IFRS S2) and TCFD recommendations, and released its third Climate Information Disclosures Report, continuously enhancing the transparency of its climate initiatives and demonstrating its steadfast long-term commitment.

The Group also actively encourages its member companies to carry out climate actions. In 2022, the Bund Finance Center (BFC), Fosun’s base in Shanghai, was awarded the LEED Platinum certification, which is hailed as the “Oscar Award” in the green building industry, with a score of 97 points to set a new world record. In August 2024, BFC was successfully included in Shanghai’s first batch of carbon peaking and carbon neutrality pilot demonstration projects, making it the only large-scale commercial complex exceeding 200,000 square meters on the list.

During the 29th session of the Conference of the Parties (COP29), Fosun Insurance Portugal (Fidelidade), a member company of Fosun, launched the Impact Center for Climate Change (ICCC), a platform for the study, research and sharing of knowledge with society, to drive innovation in climate risk knowledge and enhance the insurance industry’s climate resilience. In February 2026, the ICCC held its annual Climate Research and Industry Exchange Conference, unveiling Portugal’s first innovative study on forest fire risks to translate climate science into practical insurance risk management.

Actively driving global sustainable development and achieving outstanding ESG ratings

With a focus on core business development, Fosun leverages its comprehensive global industrial ecosystem to conduct responsible operations across more than 40 countries and regions, continuously contributing to public welfare and creating sustainable value worldwide. In addition, Fosun has long been committed to philanthropy in areas such as rural revitalization, healthcare, educational equity, community building, culture and art, steadily expanding its community impact and striving to build a more responsible, inclusive and sustainable future.

As a responsible global citizen, Fosun officially joined the United Nations Global Compact (“UN Global Compact”) in 2014. It fully supports the ten principles of the UN Global Compact on human rights, labor, environment and anti-corruption, and has deeply integrated these principles into the Group’s sustainable development strategy and code of conduct. Despite persistent global macroeconomic uncertainties, Fosun remains steadfast in advancing its sustainable development, fulfilling its long-term commitments on key issues and earning continued international recognition.

Fosun International’s ongoing efforts have earned growing recognition from international rating agencies for its ESG management. Fosun has been included in the FTSE4Good Index Series for five consecutive years and has maintained its HSI ESG rating at AA-. In 2025, Fosun’s FTSE Russell ESG score rose to 4.2. It also ranked in the top 5% among global peers in S&P Global’s Corporate Sustainability Assessment (CSA), was included in S&P Global’s Sustainability Yearbook 2025 (Global Edition), and was selected as the top 1% in S&P Global’s Sustainability Yearbook (China Edition).

Australia’s Most Recommended Real Estate Professionals Unveiled at 2026 RateMyAgent Awards

MELBOURNE, Australia, Feb. 27, 2026 /PRNewswire/ — RateMyAgent, Australia’s leading review and ratings platform, has officially announced the winners of the 2026 Agent of the Year Awards. This year’s winners represent the elite echelon of the property industry, with the nominee pool accounting for a staggering $85.8 billion in total sale value over the 2025 calendar year.

Now in its eleventh year, the awards are the only industry honors determined by verified customer feedback rather than just sales volume. The 2026 results were fueled by over 140,000 verified reviews received on the platform over 2025. The 2026 winners were calculated using a rigorous process independently reviewed by global accounting firm RSM to ensure total transparency and fairness.

2026 National Award Highlights:

The gala event, held at Melbourne’s Glasshouse and hosted by Andrew Gill, brought together the country’s elite property professionals, featuring keynote insights from RateMyAgent CEO Jim Crisera and Domain Sales Director Damien Brooks.

“These awards aren’t about who has the biggest marketing budget; they are about who provides the best experience for Australian homeowners,” said RateMyAgent CEO Jim Crisera. “By focusing on verified feedback, we empower consumers to move forward with confidence, knowing they are working with a trusted expert in their local market.”

With the 2026 property market facing unique shifts in interest rates and supply, the role of a trusted local expert has never been more critical. This year’s winners represent the top 1% of the industry who have consistently raised the bar for service excellence.

View the full list of National, State, and Territory winners here: https://resources.ratemyagent.com/au-awards-2026-winners

About RateMyAgent & Renowned:

RateMyAgent (ASX: RMY) helps homeowners select trusted real estate professionals. Operating in the United States of America, Australia and New Zealand, RateMyAgent continues to lead the global market in championing agents that are dedicated to exceptional client service.

RateMyAgent is the consumer-facing platform of the Renowned brand. Renowned is the real estate industry’s first fully integrated Local Expert Marketing (LEM) solution. Renowned turns verified reviews, past performance, listings, and hyperlocal insights into content that wins trust and builds agent reputation across the digital channels that matter most.

Renowned is used by over 350,000 agents and over 11,000 real estate offices worldwide.

For more information, please visit ratemyagent.com.au or renowned.com/au

Follow RateMyAgent on Facebook, Instagram, and LinkedIn.

 

Illumina Launches TruPath Genome, Unveils NovaSeq X Roadmap, and Drives Cancer Breakthroughs with Connected Multiomics

  • TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflow, and the new AGBT data demonstrates its accuracy in detecting rare genetic diseases
  • 40% increase in output to 35 billion reads, up to Q70 quality scores, improved turnaround time, and staggered starts are among the updates to be rolled out on all NovaSeq X systems, advancing precision medicine and delivering compounded value for NovaSeq X customers
  • At AGBT, researchers reveal new findings from studies leveraging Illumina’s multiomics solutions

SAN DIEGO, Feb. 27, 2026 /PRNewswire/ — Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a suite of powerful advancements that will significantly accelerate the next era of genomic discovery. Unveiled at the Advances in Genome Biology and Technology (AGBT) 2026 conference, the announcements include the launch of TruPath™ Genome, a new standard in genomic insight; a groundbreaking roadmap for the NovaSeq X Series; and new partner-driven cancer breakthroughs powered by Illumina’s spatial and multiomic technologies.

TruPath Genome, a new standard in genomic insight

Illumina’s launch of TruPath™ Genome sets a new standard for high-quality, comprehensive whole genome insights for genetic disease. TruPath Genome has been found to deliver unparalleled accuracy and resolution – even across so-called “dark regions” of the genome – providing researchers with a more complete picture of genomic alterations implicated in genetic disease.


With an incredibly simple workflow, TruPath Genome eliminates traditional library prep. In just 10-15 minutes of hands-on time, TruPath Genome generates 16 whole genomes per day, nearly double the throughput of competing long-read methods, and with fewer errors.

TruPath Genome leverages novel on-flow cell library preparation with patterned flow cell technology and advanced informatics to seamlessly add long-distance insights for comprehensive variant detection. DRAGEN™ algorithms tuned to incorporate proximity information from TruPath flow cells improve read alignment and variant calling, extending Illumina high quality reads to difficult-to-map regions, variant phasing, structural variants, short tandem repeats (STR), and clinically relevant paralogous genes. TruPath Genome fully phases up to 98% of genes.

The TruPath Genome launch was unveiled during the Gold Sponsor Workshop at the AGBT annual meeting in Orlando. Register here for the replay. For more detailed information on this announcement, please see the press release here, and learn more about TruPath Genome here. TruPath Genome was previously referred to as “constellation mapped read technology”. 

Roadmap of groundbreaking NovaSeq X advancements in data quality, output, speed, and flexibility 

Building on the revolutionary NovaSeq™ X Series, Illumina unveiled an 18-month roadmap of innovations that enhance the power and value of the NovaSeq X system. Updates include technology that will deliver up to a Q70 quality score for the first time, along with 30% increased speed and output up to 35 billion reads (35B). Staggered starts and new flow cells go live across the customer base in the coming weeks.


Together, these advances increase daily sequencing productivity and expand the range of applications that can be run at scale on a single instrument. With higher output, increased accuracy, faster run times, and new flexible workflow modes, the roadmap delivers compounded value for customers seeking better, faster, and more cost-effective sequencing for their most demanding applications. Improved accuracy ushers in a new era for applications that require ultrasensitivity. Upon rollout, these updates will enhance the performance and value of the 890 NovaSeq X systems installed globally—the world’s largest high-throughput sequencing fleet. 

These advances—together with a growing portfolio of multiomic and oncology-focused assays—accelerate Illumina’s ability to deliver higher-quality data at a lower total cost. The updates also set the company on track to scale access to whole-genome sequencing research in oncology, including highly sensitive molecular residual disease (MRD) testing, and genetic disease.

For more detailed information on this announcement, please see the press release here, and learn more about the NovaSeq X here.  

Going beyond the genome to advance cancer research using spatial transcriptomics, epigenomics, and proteomics

Illumina and its partners are pushing the boundaries of oncology, powered by Illumina’s spatial transcriptomics, 5-base sequencing, and proteomics technologies. The ability to combine more than one omic insight reveals unprecedented biological depth and knowledge, all of which is streamlined by Illumina Connected Multiomics for multimodal data analysis. The combined portfolio delivers new insights for precision diagnostics, targeted therapeutics development, and understanding of tumor microenvironments.

“Unlocking the human genome has changed the face of cancer care and opened up demand for the next wave of biological insights,” said Jacob Thaysen, chief executive officer at Illumina. “Researchers are rapidly adopting multiomics and informatics technologies that expand our understanding of biology at scale. Illumina’s streamlined multiomics workflows are enabling customers to achieve game-changing breakthroughs in oncology, pharmacogenomics, and more.”

For more detailed information on this announcement, please see the press release here, and learn more about Illumina’s activity at AGBT here.

Use of forward-looking statements
This release may contain forward-looking statements that involve risks and uncertainties. Among the important factors to which our business is subject that could cause actual results to differ materially from those in any forward-looking statements are: (i) our ability to successfully implement NovaSeq X updates on a cost-effective and timely basis; (ii) challenges inherent in researching, developing and launching new products, services and technologies, including modifying and scaling manufacturing operations, and reliance on third-party suppliers for critical components; (iii) our ability to manufacture robust instrumentation and consumables and develop reliable software solutions;  (iv) the acceptance and adoption by customers of our newly launched or updated products, which may or may not meet our and their expectations; (v ) our ability to deploy new products, services, and applications, and to expand the markets for genomics-related products and services, and  together with other factors detailed in our filings with the Securities and Exchange Commission, including our most recent filings on Forms 10-K and 10-Q, or in information disclosed in public conference calls, the date and time of which are released beforehand. We undertake no obligation, and do not intend, to update these forward-looking statements, to review or confirm analysts’ expectations, or to provide interim reports or updates on the progress of the current quarter.

About Illumina
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit illumina.com and connect with us on X, Facebook, LinkedIn, Instagram, TikTok, and YouTube. 

ImmVira’s Oncolytic Product MVR-T3011 Expanded to BCG-Naïve Bladder Cancer Patients for the First Time with Clinical Data Presented at the 2026 ASCO GU Conference

SUZHOU, China, Feb. 27, 2026 /PRNewswire/ — Intravesical BCG is the standard of care (SOC) for BCG-naïve high-risk non-muscle-invasive bladder cancer (NMIBC) patients. However, the scarcity of BCG products has become a global phenomenon, and coupled with the side effects of BCG therapy itself, means that a substantial number of patients cannot access effective BCG treatment. Therefore, it is essential to seek better alternative therapies to BCG in order to meet clinical needs. Based on this, ImmVira Group is further expanding the clinical trial of its core oncolytic virus product, MVR-T3011—originally targeting BCG-unresponsive high-risk bladder cancer—to further include BCG-naïve bladder cancer patients.

On February 26, 2026, at the ASCO GU 2026 Conference in San Francisco, California, ImmVira Group announced preliminary positive results from its clinical trial evaluating MVR-T3011, an oncolytic virus, in BCG-naïve high-risk papillary Ta/T1 NMIBC patients for its leading oncolytic virus product, MVR-T3011, via intravesical administration. The data were presented in a poster at the Conference.

In the study involving 18 BCG-naïve high-risk papillary Ta/T1 NMIBC patients treated with intravesical MVR-T3011 at two dose levels: 2×109 PFU (3 patients) and 1×1010 PFU (15 patients), preliminary data as of December 31, 2025, demonstrated encouraging efficacy and durability. Among the 14 evaluable patients, the 12-month recurrence-free-survival (RFS) rate was 100% (3/3) at the 2×109 PFU dose level. At the 1×1010 PFU dose level, the 3-month RFS rate was 100% (11/11). The 6-month and 9-month RFS rates were 75% (3/4) and 66.7% (2/3), respectively, but these data are preliminary, given the small patient numbers reaching those timepoints.

Consistent with BCG-unresponsive clinical data, MVR-T3011 maintained a favorable safety profile in this study with most treatment-emergent adverse events (TEAEs) being at Grades 1 or 2. No treatment-related adverse events (TRAEs) were observed.

Bladder cancer ranks as the ninth most prevalent cancer worldwide[1], with approximately 75% of cases classified as NMIBC. While Bacillus Calmette-Guerin (BCG) remains the current SOC for high-risk NMIBC, global shortages have limited its availability. As a result, oncolytic immunotherapy, which offers enhanced immune activation and potential durability, is emerging as a promising alternative.

“We are highly encouraged by the preliminary efficacy and safety data from the study,” said Dr. Grace Zhou, Chairwoman and CEO of ImmVira. “MVR-T3011 shows its potential to serve as a reliable and widely accessible alternative to BCG, ultimately benefiting patients worldwide.”

Source:
1. GLOBOCAN 2022: Bladder cancer 9th most common worldwide

About MVR-T3011

MVR-T3011, represents a breakthrough in HSV-1-based oncolytic immunotherapy. Its proprietary “3-in-1” design unites a replication-competent, tumor-lytic HSV-1 backbone with anti-PD-(L)1 antibody and IL-12, enabling it simultaneously to lyse tumor cells and stimulate innate and adaptive immunity. MVR-T3011 has demonstrated its adaptability and feasibility across multiple routes of administration including intratumoral, intracavitary and intravenous administrations.

About ImmVira

ImmVira is a clinical-stage biotechnology company that is powered by proprietary biological engineering technology, and is dedicated to the discovery, development, manufacture and commercialization of novel oncolytic immunotherapies and engineered exosome therapies. We have strategically designed, self-discovered, and built a risk-balanced product portfolio that comprised two oncolytic immunotherapy candidates for solid tumors and five engineered exosome assets poised for clinical application or direct commercialization. Driven by our vision to become a global leader in the full spectrum of bladder cancer treatment development and unlock the therapeutical potential of oncolytic immunotherapy in head and neck squamous cell carcinoma (HNSCC), we have adopted a rationalized, adaptive approach to advance oncolytic immunotherapy candidates with high clinical potential globally. In parallel, leveraging our deep expertise in biological engineering, we have pioneered development of engineered exosome candidates targeting chronic, hard-to-treat diseases as well as age-related conditions. These selected engineered exosome assets are being accelerated through differentiated regulatory pathways to enable expedited commercialization and generate sustainable cash flows that will fuel our broader drug development efforts.

 

Netflix Declines to Raise Offer for Warner Bros.

HOLLYWOOD, Calif., Feb. 27, 2026 /PRNewswire/ — Netflix, Inc. today announced that it has declined to raise its offer for Warner Bros. Netflix had earlier received notice from Warner Bros. Discovery (WBD) that its Board of Directors has determined Paramount Skydance’s (PSKY) latest proposal constitutes a “Superior Proposal” under the terms of WBD’s existing merger agreement with Netflix. Netflix issued the following statement in response from co-CEOs Ted Sarandos and Greg Peters:

The transaction we negotiated would have created shareholder value with a clear path to regulatory approval. However, we’ve always been disciplined, and at the price required to match Paramount Skydance’s latest offer, the deal is no longer financially attractive, so we are declining to match the Paramount Skydance bid.

Warner Bros. is a world-class organization, and we want to thank David Zaslav, Gunnar Wiedenfels, Bruce Campbell, Brad Singer and the WBD Board for running a fair and rigorous process. We believe we would have been strong stewards of Warner Bros.’ iconic brands, and that our deal would have strengthened the entertainment industry and preserved and created more production jobs in the U.S.  But this transaction was always a ‘nice to have’ at the right price, not a ‘must have’ at any price.

Netflix’s business is healthy, strong and growing organically, powered by our slate and best-in-class streaming service. This year, we’ll invest approximately $20 billion in quality films and series and will expand our entertaining offering. Consistent with our capital allocation policy, we’ll also resume our share repurchase program.

We will continue to do what we’ve done for more than 20 years as a public company: delight our members, profitably grow our business, and drive long-term shareholder value.

About Netflix

Netflix is one of the world’s leading entertainment services offering TV series, films, games and live programming across a wide variety of genres and languages. Members can play, pause and resume watching as much as they want, anytime, anywhere, and can change their plans at any time.

Important Information and Where to Find It

In connection with the proposed transaction between Netflix and WBD, WBD filed a definitive proxy statement on Schedule 14A (the “Proxy Statement”) with the U.S. Securities and Exchange Commission (the “SEC”). The Proxy Statement was first mailed to WBD stockholders on or around February 17, 2026. Each of Netflix and WBD may also file with or furnish to the SEC other relevant documents regarding the proposed transaction. This communication is not a substitute for the Proxy Statement or any other document that Netflix or WBD may file with the SEC or mail to WBD’s stockholders in connection with the proposed transaction. INVESTORS AND SECURITY HOLDERS OF NETFLIX AND WBD ARE URGED TO READ THE PROXY STATEMENT, AS WELL AS ANY OTHER RELEVANT DOCUMENTS FILED WITH THE SEC IN CONNECTION WITH THE PROPOSED TRANSACTION OR INCORPORATED BY REFERENCE INTO THE PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO), BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION REGARDING NETFLIX, WBD, THE PROPOSED TRANSACTION AND RELATED MATTERS. Investors and security holders may obtain free copies of the Proxy Statement as well as other filings containing information about Netflix and WBD, without charge, at the SEC’s website, https://www.sec.gov. The documents filed by Netflix with the SEC also may be obtained free of charge at Netflix’s website at https://ir.netflix.net/home/default.aspx. The documents filed by WBD with the SEC also may be obtained free of charge at WBD’s website at https://ir.wbd.com.

Participants in the Solicitation

Netflix, WBD and certain of their respective directors and executive officers may be deemed to be participants in the solicitation of proxies from the stockholders of WBD in connection with the proposed transaction under the rules of the SEC. Information about the interests of the directors and executive officers of WBD and other persons who may be deemed to be participants in the solicitation of stockholders of WBD in connection with the proposed transaction and a description of their direct and indirect interests, by security holdings or otherwise, is included in the Proxy Statement, which has been filed by WBD with the SEC. Information about WBD’s directors and executive officers is set forth in WBD’s proxy statement for its 2025 Annual Meeting of Stockholders on Schedule 14A filed with the SEC on April 23, 2025, WBD’s Annual Report on Form 10-K for the year ended December 31, 2024, and any subsequent filings with the SEC. Information about Netflix’s directors and executive officers is set forth in Netflix’s proxy statement for its 2025 Annual Meeting of Stockholders on Schedule 14A filed with the SEC on April 17, 2025, and any subsequent filings with the SEC. Additional information regarding the direct and indirect interests of those persons and other persons who may be deemed participants in the proposed transaction may be obtained by reading the Proxy Statement regarding the proposed transaction. Free copies of these documents may be obtained as described above.

Cautionary Statement Regarding Forward-Looking Statements

This document contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are based on Netflix’s and WBD’s current expectations, estimates and projections about the expected date of closing of the proposed transaction and the potential benefits thereof, their respective businesses and industries, management’s beliefs and certain assumptions made by Netflix and WBD, all of which are subject to change. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “could,” “seek,” “see,” “will,” “may,” “would,” “might,” “potentially,” “estimate,” “continue,” “expect,” “target,” similar expressions or the negatives of these words or other comparable terminology that convey uncertainty of future events or outcomes. All forward-looking statements by their nature address matters that involve risks and uncertainties, many of which are beyond our control and are not guarantees of future results, such as statements about the consummation of the proposed transaction and the anticipated benefits thereof. These and other forward-looking statements, including the failure to consummate the proposed transaction or to make or take any filing or other action required to consummate the transaction on a timely matter or at all, are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements. Accordingly, there are or will be important factors that could cause actual results to differ materially from those indicated in such statements and, therefore, you should not place undue reliance on any such statements and caution must be exercised in relying on forward-looking statements. Important risk factors that may cause such a difference include, but are not limited to: (i) the completion of the proposed transaction on anticipated terms and timing, including obtaining stockholder and regulatory approvals, completing the separation of WBD’s Discovery Global business (“Discovery Global”) and Warner Bros. business, anticipated tax treatment, unforeseen liabilities, future capital expenditures, revenues, expenses, earnings, synergies, economic performance, indebtedness, financial condition, losses, future prospects, business and management strategies, expansion and growth of WBD’s and Netflix’s businesses and other conditions to the completion of the proposed transaction; (ii) failure to realize the anticipated benefits of the proposed transaction, including as a result of delay in completing the transaction or integrating the businesses of Netflix and WBD; (iii) Netflix’s and WBD’s ability to implement their business strategies; (iv) consumer viewing trends; (v) potential litigation relating to the proposed transaction that could be instituted against Netflix, WBD or their respective directors; (vi) the risk that disruptions from the proposed transaction will harm Netflix’s or WBD’s business, including current plans and operations; (vii) the ability of Netflix or WBD to retain and hire key personnel; (viii) potential adverse reactions or changes to business relationships resulting from the announcement, pendency or completion of the proposed transaction; (ix) uncertainty as to the long-term value of Netflix’s common stock; (x) legislative, regulatory and economic developments affecting Netflix’s and WBD’s businesses; (xi) general economic and market developments and conditions; (xii) the evolving legal, regulatory and tax regimes under which Netflix and WBD operate; (xiii) potential business uncertainty, including changes to existing business relationships, during the pendency of the proposed transaction that could affect Netflix’s or WBD’s financial performance; (xiv) restrictions during the pendency of the proposed transaction that may impact Netflix’s or WBD’s ability to pursue certain business opportunities or strategic transactions; (xv) failure to receive the approval of the stockholders of WBD; (xvi) the final allocation of indebtedness between WBD and Discovery Global in connection with the separation could cause a reduction to the consideration for the proposed transaction; (xvii) inherent uncertainties involved in the estimates and assumptions used in the preparation of financial projections, and inherent uncertainties involved in the estimates and judgments used to estimate the differences between WBD’s Global Linear Networks segment results and the expected results of Discovery Global; and (xviii) volatility or a decline in the market price for Discovery Global common stock following the separation. Discussions of additional risks and uncertainties are contained in Netflix’s and WBD’s filings with the SEC, including their Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, and the Proxy Statement filed by WBD in connection with the proposed transaction. While the list of factors presented here and in the Proxy Statement are considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on Netflix’s or WBD’s consolidated financial condition, results of operations or liquidity. Neither Netflix nor WBD assumes any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.

Jacobi Launches Suite of AI-Assisted Coding Resources to Accelerate Custom Investment Technology Development

BRISBANE, Australia, Feb. 27, 2026 /PRNewswire/ — Jacobi Strategies (Jacobi), a global leader in investment technology, today announced the launch of its AI-Assisted Coding Resources, a powerful new suite of tools designed to help investment teams rapidly build, standardise, and scale bespoke analytics and applications within their secure, private Jacobi environment.

Jacobi’s new AI resources enable investment firms to standardise the development process, enabling complex, production-grade solutions to be built with unprecedented speed and consistency. Developers can now leverage modern AI assistants like GitHub Copilot, Cursor, and Claude Code within their secure Jacobi instance. Key features include:

  • Jacobi Rules: Provides essential global context, ensuring AI-generated code adheres to Jacobi’s recommended architecture, development patterns, and language-specific coding standards.
  • Jacobi Skills: Offers procedural, multi-step instructions for common tasks, such as creating new plugins, querying internal data, and implementing complex modeling.
  • Jacobi Model Context Protocol Server: Acts as a secure, open-standard bridge that allows AI tools to safely interact with Jacobi APIs, explore data schemas, retrieve system objects and control platform actions through natural-language prompts.

Building on a Foundation of Security and Governance 

These AI capabilities are delivered via Jacobi’s Infrastructure-as-a-Service (IaaS). Each client receives a private instance – including cloud infrastructure, horizontal scaling, and dedicated containerisation – ensuring proprietary models and data remain within a secure, governed perimeter.

Unlocking Next-Generation AI Agents for Investment Teams

The release coincides with the launch of new Jacobi AI agents integrated directly into the platform. Built for the rigorous demands of institutional managers, these “next generation” agents execute complex, multi-step workflows where precision is mandatory.

By combining Jacobi’s AI-assisted coding resources with its IaaS, firms can rapidly build, scale, and govern custom tools. These tools – which include Jacobi Graph Scripts for modular analytics and visualisations, alongside full end-to-end applications – can then be seamlessly deployed across connected workflows using agents internal or external to the Jacobi ecosystem.

This launch reinforces Jacobi’s commitment to open-architecture, API-first design, allowing clients to seamlessly integrate Jacobi-driven tools into their broader enterprise systems while maintaining total control over their IP.

Tony Mackenzie, Co-Founder and CEO of Jacobi, commented:

“Our AI-assisted coding resources are not designed to replace investment expertise, but to empower it. By providing a secure environment for custom analytics and applications, we remove the trade-off between in-house flexibility and enterprise-grade security.

A significant gap remains between individual AI adoption and enterprise-level use, which requires heightened control over standards and security. Jacobi’s scalable infrastructure and experience with top-tier asset managers makes our technology uniquely suited to firms moving beyond prototyping towards delivery of robust AI solutions.”

About Jacobi

Jacobi provides a secure, private investment technology allowing firms to harness modern AI to scale portfolio construction, analytics and investment workflows. Its open architecture technology empowers several of the world’s leading investment managers to build differentiated tools and models on top of a robust, investment-specific data foundation.

To learn more about Jacobi’s AI-Assisted Coding, please visit https://lp.jacobistrategies.com/jacobi-ai-assisted-coding-resource-enquiry